{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:40:32Z","timestamp":1784292032538,"version":"3.55.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.prp.2020.152919","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T04:29:04Z","timestamp":1583728144000},"page":"152919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Targeting cancer stem cells by melatonin: Effective therapy for cancer treatment"],"prefix":"10.1016","volume":"216","author":[{"given":"Nazila Fathi","family":"Maroufi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Vahedian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saideh","family":"Hemati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Reza","family":"Rashidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Akbarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadsaeid","family":"Zahedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Pouremamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Isazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Taefehshokr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Hajazimian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikou","family":"Seraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5367-9956","authenticated-orcid":false,"given":"Mohammad","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2020.152919_bib0005","article-title":"Prostate cancer statistics | world Cancer research fund","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prp.2020.152919_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117106","article-title":"Therapeutic potentials of Apatinib in cancer treatment: possible mechanisms and clinical relevance","volume":"241","author":"Fathi Maroufi","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2020.152919_bib0015","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/jpi.12227","article-title":"Melatonin as a treatment for gastrointestinal cancer: a review","volume":"58","author":"Xin","year":"2015","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.prp.2020.152919_bib0020","series-title":"Stem Cell Biol. Heal. Dis.","first-page":"295","article-title":"Cancer stem cells in solid tumors","author":"Nafus","year":"2009"},{"key":"10.1016\/j.prp.2020.152919_bib0025","doi-asserted-by":"crossref","first-page":"14759","DOI":"10.1002\/jcp.28271","article-title":"Current approaches in identification and isolation of cancer stem cells","volume":"234","author":"Akbarzadeh","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.prp.2020.152919_bib0030","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4048\/jbc.2015.18.4.303","article-title":"New findings on breast cancer stem cells: a review","volume":"18","author":"Bozorgi","year":"2015","journal-title":"J. Breast Cancer"},{"key":"10.1016\/j.prp.2020.152919_bib0035","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.prp.2020.152919_bib0040","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1053\/j.gastro.2009.12.063","article-title":"Colon Cancer stem cells: promise of targeted therapy","volume":"138","author":"Todaro","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prp.2020.152919_bib0045","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1158\/1535-7163.MCT-10-0563","article-title":"Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer","volume":"9","author":"Landen","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.prp.2020.152919_bib0050","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/sj.cdd.4402283","article-title":"Identification and expansion of the tumorigenic lung cancer stem cell population","volume":"15","author":"Eramo","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.prp.2020.152919_bib0055","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1073\/pnas.0610117104","article-title":"Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma","volume":"104","author":"Prince","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.prp.2020.152919_bib0060","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.seminoncol.2015.01.001","article-title":"Cancer stem cells: the promise and the potential","volume":"42","author":"Ajani","year":"2015","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.prp.2020.152919_bib0065","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrclinonc.2010.196","article-title":"Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways","volume":"8","author":"Takebe","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.prp.2020.152919_bib0070","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.molcel.2014.05.015","article-title":"Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance","volume":"54","author":"Easwaran","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.prp.2020.152919_bib0075","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16940-y","article-title":"The potential therapeutic effect of melatonin on human ovarian cancer by inhibition of invasion and migration of cancer stem cells","volume":"7","author":"Akbarzadeh","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2020.152919_bib0080","article-title":"D.A. Pires De Campos Zuccari, Effect of melatonin in epithelial mesenchymal transition markers and invasive properties of breast cancer stem cells of canine and human cell lines","volume":"11","author":"Do Nascimento Gon\u00e7alves","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2020.152919_bib0085","doi-asserted-by":"crossref","first-page":"9789","DOI":"10.1158\/0008-5472.CAN-06-1776","article-title":"Melatonin in cancer management: progress and promise","volume":"66","author":"Jung","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2020.152919_bib0090","doi-asserted-by":"crossref","first-page":"39896","DOI":"10.18632\/oncotarget.16379","article-title":"Melatonin for the prevention and treatment of cancer","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.prp.2020.152919_bib0095","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12519","article-title":"Melatonin and 5-fluorouracil co-suppress colon cancer stem cells by regulating cellular prion protein-Oct4 axis","volume":"65","author":"Lee","year":"2018","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.prp.2020.152919_bib0100","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/jpi.12341","article-title":"Melatonin inhibits tumorigenicity of glioblastoma stem-like cells via the AKT\u2013EZH2\u2013STAT3 signaling axis","author":"Chen","year":"2016","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.prp.2020.152919_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-019-1036-z","article-title":"Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS\/hTERT signaling and cancer-stem cell traits","volume":"38","author":"Hao","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.prp.2020.152919_bib0110","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.bone.2013.02.021","article-title":"Melatonin inhibits the proliferation of human osteosarcoma cell line MG-63","volume":"55","author":"Liu","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.prp.2020.152919_bib0115","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.semcancer.2012.04.001","article-title":"Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links","volume":"22","author":"Scheel","year":"2012","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.prp.2020.152919_bib0120","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/jcp.21140","article-title":"Cancer stem cells in leukemia, recent advances","volume":"213","author":"Zou","year":"2007","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.prp.2020.152919_bib0125","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-7-56","article-title":"Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB","volume":"7","author":"Li","year":"2009","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.prp.2020.152919_bib0130","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1136\/jcp.2010.087213","article-title":"Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma","volume":"64","author":"Xi","year":"2011","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.prp.2020.152919_bib0135","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-011-1703-6","article-title":"Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution","author":"Metellus","year":"2011","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.prp.2020.152919_bib0140","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3892\/or_00000890","article-title":"Cytoplasmic expression of CD133 is an important risk factor for overall survival in hepatocellular carcinoma","volume":"24","author":"Sasaki","year":"2010","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.prp.2020.152919_bib0145","first-page":"2453","article-title":"Prognostic impact of CD133 expression in gastric carcinoma","volume":"30","author":"Ishigami","year":"2010","journal-title":"Anticancer Res."},{"key":"10.1016\/j.prp.2020.152919_bib0150","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.humpath.2010.05.006","article-title":"Prognostic impact of CD133 expression as a tumor-initiating cell marker in endometrial cancer","volume":"41","author":"Nakamura","year":"2010","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2020.152919_bib0155","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1158\/0008-5472.CAN-10-3175","article-title":"Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival","volume":"71","author":"Silva","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2020.152919_bib0160","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.3892\/or.2013.2294","article-title":"Prognostic value of cancer stem cells, epithelial-mesenchymal transition and circulating tumor cells in lung cancer","volume":"29","author":"Pirozzi","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.prp.2020.152919_bib0165","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1158\/0008-5472.CAN-12-0299","article-title":"CD44s regulates the TGF-\u03b2-mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma","volume":"72","author":"Mima","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2020.152919_bib0170","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-018-0605-5","article-title":"The biology and role of CD44 in cancer progression: therapeutic implications","volume":"11","author":"Chen","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.prp.2020.152919_bib0175","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000491667","article-title":"CD24 is a potential biomarker for prognosis in human breast carcinoma","volume":"48","author":"Jing","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.prp.2020.152919_bib0180","doi-asserted-by":"crossref","DOI":"10.1186\/bcr3648","article-title":"Changes in aldehyde dehydrogenase-1 expression during neoadjuvant chemotherapy predict outcome in locally advanced breast cancer","volume":"16","author":"Alamgeer","year":"2014","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.prp.2020.152919_bib0185","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1177\/0300060514527060","article-title":"Aldehyde dehydrogenase 1 (ALDH1) positivity correlates with poor prognosis in cervical cancer","volume":"42","author":"Yao","year":"2014","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.prp.2020.152919_bib0190","doi-asserted-by":"crossref","DOI":"10.1007\/s00210-019-01692-5","article-title":"Sensitization of MDA-MBA231 breast cancer cell to docetaxel by myricetin loaded into biocompatible lipid nanoparticles via sub-G1 cell cycle arrest mechanism","volume":"393","author":"Maroufi","year":"2020","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.prp.2020.152919_bib0195","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/21691401.2017.1423493","article-title":"Improved anticancer effects of epigallocatechin gallate using RGD-containing nanostructured lipid carriers","volume":"46","author":"Hajipour","year":"2018","journal-title":"Artif. Cells, Nanomed. Biotechnol."},{"key":"10.1016\/j.prp.2020.152919_bib0200","first-page":"1290","article-title":"In vivo and in vitro impact of miR-31 and miR-143 on the suppression of metastasis and invasion in breast cancer","volume":"23","author":"Soheilyfar","year":"2018","journal-title":"J. B.U.ON"},{"key":"10.1016\/j.prp.2020.152919_bib0205","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1158\/1078-0432.1154.11.3","article-title":"Prevalence of CD44+\/CD24-\/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis","volume":"11","author":"Abraham","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2020.152919_bib0210","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1158\/1078-0432.CCR-09-1630","article-title":"Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer","volume":"16","author":"Charafe-Jauffret","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2020.152919_bib0215","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1634\/stemcells.2006-0426","article-title":"Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells","volume":"25","author":"Babaie","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.prp.2020.152919_bib0220","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1600-079X.2004.00207.x","article-title":"Melatonin-estrogen interactions in breast cancer","volume":"38","author":"S\u00e1nchez-Barcel\u00f3","year":"2005","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.prp.2020.152919_bib0225","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cdp.2006.03.002","article-title":"Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions","volume":"30","author":"Cos","year":"2006","journal-title":"Cancer Detect. Prev."},{"key":"10.1016\/j.prp.2020.152919_bib0230","doi-asserted-by":"crossref","first-page":"209","DOI":"10.18632\/genesandcancer.107","article-title":"Melatonin decreases estrogen receptor binding to estrogen response elements sites on the oct4 gene in human breast cancer stem cells","volume":"7","author":"Lopes","year":"2016","journal-title":"Genes Cancer"},{"key":"10.1016\/j.prp.2020.152919_bib0235","first-page":"5048","article-title":"Investigation of autophagic effects of melatonin on breast cancer stem cells","volume":"28","author":"Donmez","year":"2017","journal-title":"Biomed. Res."},{"key":"10.1016\/j.prp.2020.152919_bib0240","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.molonc.2010.08.001","article-title":"Brain tumor stem cells: the cancer stem cell hypothesis writ large","volume":"4","author":"Dirks","year":"2010","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.prp.2020.152919_bib0245","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nm.2304","article-title":"The cancer stem cell: premises, promises and challenges","volume":"17","author":"Clevers","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.prp.2020.152919_bib0250","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.canlet.2009.06.016","article-title":"Melatonin sensitizes human malignant glioma cells against TRAIL-induced cell death","volume":"287","author":"Mart\u00edn","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2020.152919_bib0255","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/jpi.12170","article-title":"Involvement of autophagy in melatonin-induced cytotoxicity in glioma-initiating cells","volume":"57","author":"Mart\u00edn","year":"2014","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.prp.2020.152919_bib0260","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12556","article-title":"Inhibition of TFEB oligomerization by co-treatment of melatonin with vorinostat promotes the therapeutic sensitivity in glioblastoma and glioma stem cells","volume":"66","author":"Sung","year":"2019","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.prp.2020.152919_bib0265","doi-asserted-by":"crossref","first-page":"245","DOI":"10.7150\/ijbs.16818","article-title":"Melatonin inhibits glioblastoma stem-like cells through suppression of EZH2-NOTCH1 signaling axis","volume":"13","author":"Zheng","year":"2017","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.prp.2020.152919_bib0270","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12496","article-title":"Melatonin disturbs SUMOylation-mediated crosstalk between c-Myc and nestin via MT1 activation and promotes the sensitivity of paclitaxel in brain cancer stem cells","volume":"65","author":"Lee","year":"2018","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.prp.2020.152919_bib0275","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/onc.2008.374","article-title":"Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells","volume":"28","author":"Baba","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2020.152919_bib0280","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s10354-014-0289-6","article-title":"Expression und m\u00f6gliche Funktionen von Melatonin-Rezeptoren in humanen Karzinomzellen und im Krebsgewebe","volume":"164","author":"Ekmekcioglu","year":"2014","journal-title":"Wiener Med. Wochenschr."},{"key":"10.1016\/j.prp.2020.152919_bib0285","series-title":"Chemother. Gynecol. Neoplasms Curr. Ther. Nov. Approaches","first-page":"367","article-title":"Ovarian cancer","author":"Angioli","year":"2004"},{"key":"10.1016\/j.prp.2020.152919_bib0290","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.7150\/thno.18835","article-title":"Down-regulated miR-23a contributes to the metastasis of cutaneous melanoma by promoting autophagy","volume":"7","author":"Guo","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.prp.2020.152919_bib0295","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.redox.2017.01.010","article-title":"Sensitization of melanoma cells to alkylating agent-induced DNA damage and cell death via orchestrating oxidative stress and IKK\u03b2 inhibition","volume":"11","author":"Tse","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.prp.2020.152919_bib0300","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(12)70539-9","article-title":"Which drug, and when, for patients with BRAF-mutant melanoma?","volume":"14","author":"Jang","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.prp.2020.152919_bib0305","doi-asserted-by":"crossref","DOI":"10.3390\/cancers8030034","article-title":"Melanoma cancer stem cells: markers and functions","volume":"8","author":"Parmiani","year":"2016","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2020.152919_bib0310","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-016-0578-3","article-title":"Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma","volume":"16","author":"Kumar","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2020.152919_bib0315","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-10-2538","article-title":"Cancer stem cells and chemosensitivity","author":"Maugeri-Sacc\u00e0","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2020.152919_bib0320","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.3892\/or.2017.5963","article-title":"Phenotype characterization of human melanoma cells resistant to dabrafenib","volume":"38","author":"Cordaro","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.prp.2020.152919_bib0325","doi-asserted-by":"crossref","DOI":"10.1038\/srep45704","article-title":"Genetic and epigenetic alterations of TERT are associated with inferior outcome in adolescent and young adult patients with melanoma","volume":"7","author":"Seynnaeve","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2020.152919_bib0330","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1182\/blood-2003-09-3314","article-title":"Gene expression in human embryonic stem cell lines: unique molecular signature","volume":"103","author":"Bhattacharya","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.prp.2020.152919_bib0335","first-page":"177","article-title":"Colorectal cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prp.2020.152919_bib0340","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","article-title":"Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018","volume":"103","author":"Ferlay","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.prp.2020.152919_bib0345","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature05384","article-title":"Identification and expansion of human colon-cancer-initiating cells","volume":"445","author":"Ricci-Vitiani","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.prp.2020.152919_bib0350","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ncb2680","article-title":"A unique Oct4 interface is crucial for reprogramming to pluripotency","volume":"15","author":"Esch","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.prp.2020.152919_bib0355","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/jcp.29049","article-title":"Melatonin: An important anticancer agent in colorectal cancer","volume":"235","author":"Mirza-Aghazadeh-Attari","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.prp.2020.152919_bib0360","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061251","article-title":"AA-NAT, MT1 and MT2 correlates with cancer stem-like cell markers in colorectal cancer: Study of the influence of stage and p53 status of tumors","volume":"18","author":"Casado","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2020.152919_bib0365","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1034\/j.1600-079X.2000.d01-64.x","article-title":"Potential involvement of mt1 receptor and attenuated sex steroid-induced calcium influx in the direct anti-proliferative action of melatonin on androgen-responsive LNCaP human prostate cancer cells","volume":"29","author":"Xi","year":"2000","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.prp.2020.152919_bib0370","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/bjc.2014.585","article-title":"Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review","volume":"112","author":"Daw","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2020.152919_bib0375","first-page":"2537","article-title":"Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells","volume":"10","author":"Ni","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.prp.2020.152919_bib0380","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.lfs.2018.04.030","article-title":"Melatonin inhibits osteosarcoma stem cells by suppressing SOX9-mediated signaling","volume":"207","author":"Qu","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2020.152919_bib0385","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prp.2020.152919_bib0390","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ctrv.2012.10.004","article-title":"Cancer stem cells niche: a target for novel cancer therapeutics","volume":"39","author":"Yi","year":"2013","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.prp.2020.152919_bib0395","series-title":"Encycl. Cell Biol.","first-page":"807","article-title":"Cancer stem cells","author":"Buczacki","year":"2015"},{"key":"10.1016\/j.prp.2020.152919_bib0400","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/tox.22674","article-title":"Melatonin reduces lung cancer stemness through inhibiting of PLC, ERK, p38, \u03b2-catenin, and Twist pathways","volume":"34","author":"Yang","year":"2019","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.prp.2020.152919_bib0405","first-page":"4639","article-title":"Comparisons between bio-radiation effects of X-rays and carbon-ion irradiation on glioma stem cells","volume":"10","author":"Sun","year":"2017","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.prp.2020.152919_bib0410","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1038\/bjc.2013.188","article-title":"Melatonin-induced methylation of the ABCG2\/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells","volume":"108","author":"Mart\u00edn","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2020.152919_bib0415","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6486173","article-title":"CD133 is associated with increased melanoma cell survival after multikinase inhibition","volume":"2019","author":"Simbulan-Rosenthal","year":"2019","journal-title":"J. Oncol."},{"key":"10.1016\/j.prp.2020.152919_bib0420","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nature09161","article-title":"Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271","volume":"466","author":"Boiko","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.prp.2020.152919_bib0425","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ejca.2013.11.014","article-title":"Immunology of cancer stem cells in solid tumours","volume":"50","author":"MacCalli","year":"2014","journal-title":"A review, Eur. J. Cancer."},{"key":"10.1016\/j.prp.2020.152919_bib0430","first-page":"4337","article-title":"CD24 expression predicts poor prognosis for patients with cutaneous malignant melanoma","volume":"7","author":"Tang","year":"2014","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.prp.2020.152919_bib0435","doi-asserted-by":"crossref","first-page":"8565","DOI":"10.1200\/jco.2010.28.15_suppl.8565","article-title":"CD20-immunotargeting of malignant melanoma","volume":"28","author":"Wagner","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2020.152919_bib0440","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015183","article-title":"C.A.M. la Porta, Cxcr6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells","volume":"5","author":"Taghizadeh","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2020.152919_bib0445","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.cell.2010.04.020","article-title":"A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth","volume":"141","author":"Roesch","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.prp.2020.152919_bib0450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057465","article-title":"Autochthonous mouse melanoma and mammary tumors do not express the pluripotency genes Oct4 and nanog","volume":"8","author":"Schreiber","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2020.152919_bib0455","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrclinonc.2015.61","article-title":"Targeting notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update","volume":"12","author":"Takebe","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.prp.2020.152919_bib0460","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/jid.2010.69","article-title":"Heterogeneous phenotype of human melanoma cells with in vitro and in vivo features of tumor-initiating cells","volume":"130","author":"Perego","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.prp.2020.152919_bib0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2867-13-78","article-title":"Functional features of cancer stem cells in melanoma cell lines","volume":"13","author":"Zimmerer","year":"2013","journal-title":"Cancer Cell Int."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033819330730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033819330730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:42:58Z","timestamp":1759732978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033819330730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":93,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0344033819330730"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2020.152919","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting cancer stem cells by melatonin: Effective therapy for cancer treatment","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2020.152919","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152919"}}